HomeAI · summaries
Storia in 11 fonti
Science Corporation's vision-restoring chip receives EU approval
Science Corp's PRIMA retinal implant gains EU approval, marking progress in neurotech market. Aims for $100M annual revenue to prove viability.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
‘Cochlear implant for blindness’ debuts in Europe, could launch in U.S. in 2027
Science Corporation announced the European launch of its retinal implant for patients with age-related macular degeneration.
- ·
morningstar.com
Science Corp. Announces European Commercial Launch of PRIMA, the Only Treatment to Restore Functional Central Vision to Patients with…
Science Corp. Announces European Commercial Launch of PRIMA, the Only Treatment to Restore Functional Central Vision to Patients with Geographic Atrophy Caused by Age-Related…
